priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
Published 7 years ago • 116 plays • Length 5:35
Download video MP4
Download video MP3
Similar videos
-
0:31
preview: priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
-
10:04
priority reviews in ovarian cancer, prostate cancer, nsclc, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
5:27
priority review in ovarian cancer, rolling submission in alk-positive nsclc, and more
-
0:31
onn preview: priority review in ovarian cancer, mixed results in myelofibrosis, and more
-
12:33
priority review in squamous nsclc, european recommendations across tumor types, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
10:41
fda approvals in ovarian cancer and for mec chemo, promising data in lung cancer, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
12:17
fda approvals in breast cancer and prostate cancer, priority review in breast cancer, and more
-
7:23
fda approval in nsclc, priority review in sclc, 2018 sabcs highlights, and more
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
10:25
priority reviews in prostate and bladder cancer, nccn crc guidelines update, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
Clip.africa.com - Privacy-policy